Clinical Characteristics of Breast Cancer Patients Admitted to Academic Surgical Wards in Tehran, Iran: An Analytical Cross-Sectional Study Publisher Pubmed



Pourriahi R¹ ; Omranipour R^{1, 2} ; Alipour S^{1, 3} ; Hajimaghsoudi L^{1, 4} ; Mashoori N¹ ; Kenary AY⁵ ; Motamedi M^{1, 6} ; Tavakol M¹ ; Mohammadzadeh M¹ ; Hessamiazar S¹ ; Shabani S⁷ ; Mahmoodi F⁸ ; Goodarzi MM⁹ ; Eslami B¹
Source: BMC Women's Health Published:2023

Abstract

Background: Breast cancer (BC) is the most commonly diagnosed cancer and the leading cause of cancer death among women. Knowledge of the clinical characteristics of BC in a population may be informative for disease prediction or diagnosis and for developing screening and diagnostic guidelines. This study aimed to evaluate the clinical characteristics of female patients with BC who were admitted to academic surgical wards in Tehran, Iran. Methods: In this cross-sectional study, demographic information and clinical characteristics of Iranian females with BC who had undergone breast surgery from 2017–2021 in four academic Breast Surgery Units were extracted from medical files and recorded via a pre-designed checklist. Results: A total of 1476 patients with a mean age of 48.03 (± 11.46) years were enrolled. Among them, 10.4% were aged less than 35. In younger patients, Triple-negative and Her2-enriched subtypes of BC were significantly higher compared to older ones. Overall, 85.7% of tumors were invasive ductal carcinoma, 43.3% were grade 2, 41.4% were located in the UOQ, and 65.2% had presented with mass palpation. The mean pathologic tumor size was 28.94 mm, and the most common subtype was luminal B. Conclusions: Many characteristics of breast cancer in this study were similar to other countries and previous studies in Iran. However, a higher proportion of young BC compared with Western countries, and even with older studies in Iran, suggest a trend toward lower age for BC in recent years. These results indicate the need for preventive measures and screening in Iranian women at a younger age. © 2023, BioMed Central Ltd., part of Springer Nature.